Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 16, 2021British Journal of HaematologyOpen Access

Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms

View Full Paper
Ask AI
Bookmark
Share

Authors

OCOnima ChowdhuryUniversity of OxfordHBHannah BruguierJohn Radcliffe HospitalGMGarry MallettGuy's and St Thomas' NHS Foundation Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chowdhury et al. (2021) studied this question.

synapsesocial.com/papers/6aaca5ce812bc885d43a8091https://doi.org/10.1111/bjh.17644
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host2010 · 132 citations
  2. 2Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status2021 · 141 citations
  3. 3Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines2021 · 61 citations
  4. 4Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients2020 · 664 citations
  5. 5Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia2021 · 664 citations